We hypothesize that the anti-inflammatory effect linked to inhibition of TLR4 pathway is a key mechanism associated with the reduction of AD-like pathology common to both orexigenic and anorexigenic peptides (Fig. 9). The gene discussed is TLR4; the disease is Alzheimer disease.